Joan Genescà Ferrer Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine. Institutions of which they are part Head of group Liver Diseases Vall Hebron Institut de Recerca Hepatologia General Hospital Twitter Orcid Email Joan Genescà Ferrer Twitter Orcid Email Institutions of which they are part Head of group Liver Diseases Vall Hebron Institut de Recerca Hepatologia General Hospital Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.
Projects TARGETED BIODEGRADABLE NANOPARTICLES OF SIMVASTATIN AS NEW THERAPEUTIC TOOL FOR CHRONIC LIVER DISEASE IP: Joan Genescà Ferrer Collaborators: Miriam Izquierdo Sans Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 49100 Reference: 2019 FI_B 00395 Duration: 01/06/2019 - 31/10/2022 Grup de recerca en Malalties Hepàtiques IP: Joan Genescà Ferrer Collaborators: - Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 61192 Reference: 2017SGR0374 Duration: 01/01/2017 - 30/09/2021 Sol·licitud Juan Rodés. IP: Joan Genescà Ferrer Collaborators: Macarena Simon-Talero Horga Funding agency: Instituto de Salud Carlos III Funding: 180000 Reference: JR17/00029 Duration: 01/01/2018 - 24/07/2022 Spanish Clinical Research Network (SCReN) IP: Inmaculada Fuentes Camps Collaborators: Antonio Moreno Galdó, Tamara Del Rio Higueras, Ariadna Martín Balcells, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez, Joan Genescà Ferrer Funding agency: Instituto de Salud Carlos III Funding: 319550 Reference: PT17/0017/0030 Duration: 01/01/2018 - 31/12/2020 Pagination First page « Previous page ‹ … Page 3 Page 4 Current page 5 Page 6 Page 7 … Next page › Last page »
